Ethical statement, study design and allocationEthical statement
Approval was obtained from the ethical committee of Faculty of Medicine, Mansoura University (No. R21.05.1328) in accordance with principles of laboratory animal care NIH publication revised 1985 (Code number: 2020107). Reporting of all experimental procedures complied with recommendations in ARRIVE guidelines.
Randomized, placebo-controlled, blinded animal study was conducted. The sample size was calculated using G power 3.9.1.4 software, to detect a 0.7 effect size between the null hypothesis and the alternative hypothesis with significance level of 0.05 and a power of 0.85, using a one-way ANOVA F-test. Twenty seven male Wistar rats, 100120g, were maintained in a controlled temperature (2426C), relative humidity of 6080% and on a 12-h lightdark cycle for one week acclimatization. Rats were randomly allocated using list randomizer (https://www.random.org/lists) into 3 groups with 9 rats/group as follow; Group1: served as a control, Group 2: represented diabetic rats, and Group 3: denoted as the treated group in which the diabetic rats received intraperitoneal (IP) injection of 100mg/kg/3 times a week GA (Sigma-Aldrich, St Louis, MO, USA) for 8 weeks33,34.
After overnight fasting, rats assigned to groups 2 and 3 were injected with (50mg/kg/ip) of freshly prepared streptozotocin (STZ) dissolved in citrate buffer, pH 4.5 (STZ, Sigma Chemical Co., St. Louis, MO, USA) while, the control animals in group 1 were injected by an equal volume of the buffer by the same qualified person35. Three days after the STZ injection, animals with stable fasting blood glucose levels at>250mg/dl were considered diabetic.
After eight weeks of treatment, all rats were anesthetized with Xylazine (5mg/kg, ADWIA Co. S.A.E 10 of Ramadan city, Egypt) and Ketamine (40mg/kg, Segmatec Pharmaceutical Industries Co., Egypt) injection into the peritoneum (IP) and euthanized by decapitation (at 8 am to minimize the circadian effect)36,37 and the SMG tissues were collected. The right halves were processed for the histological analysis, and the left halves were snap frozen in liquid nitrogen and kept at 80C until used for oxidative stress estimation, RT-PCR and ELISA techniques.
The 4m sections of paraformaldehyde-fixed and paraffin-embedded SMG tissues were stained with hematoxylin and eosin (H&E). For the semithin sections, tissue biopsies were dehydrated through an ascending series of ethanol (to 100%) and then washed in dry acetone and embedded in epoxy resin then stained with toluidine blue.
The protein expression of SIRT1 (Bioss Antibodies, USA, 1:200), ET-1 (Bioss Antibodies, USA, 1:200), AQP1 (Scervicebio Co., USA, 1:1000), AQP4 (Scervicebio Co., USA, 1:1500), AQP5 (ABclonal, USA, 1:200) and autophagy biomarkers LC3 (Abcam, USA, 1:1200), P62 (ABclonal, USA, 1:200) were determined in each group by incubating tissue sections in primary antibodies overnight followed by incubation with secondary antibodies to perform IHC. The visualization of slides was detected using 3,3-Diaminobenzidine (DAB, Abcam, USA), and counterstained with hematoxylin. Then, the sections were analyzed and photographed using an Olympus microscope (Japan) with installed camera. The positive reaction was thresholded and calculated in relation to the surface area using Image J. The data were then decoded and statistically analyzed.
The SMG tissue was homogenized with sodium phosphate buffer, centrifuged, and the supernatant was used for the biochemical analysis. Oxidative stress markers; reduced glutathione (GSH), superoxide dismutase (SOD) and malondialdehyde (MDA) were measured spectrophotometrically38,39.
Rat Beclin-1 ELISA Kit (MBS733192) and Rat LC3II ELISA kit (MBS169564) were used for quantitative measurement of Beclin-1and LC3II protein levels in the SMG homogenate according to the manufacturers instructions.
Total RNA was extracted from SMG samples, and then RNA quality and purity were assured. Then cDNA was synthesized from RNA. The cDNA was amplified and used in SYBR Green Based Quantitative Real-Time PCR. For Relative Quantification (RQ) of LC3 gene expression, a primer with Gene Bank Accession No. NM_022867.2, Forward sequence: 5-ACG-GCT-TCC-TGT-ACA-TGG-TC-3 and Reverse sequence: 5-GTG-GGT-GCC-TAC-GTT-CTG-AT was used. And for AQP5, a primer with Gene Bank Accession No. NM_012779.2 was used. The forward primer sequence was 5-GGGCCATCTTGTGGGGATCT-3 and the reverse primer sequence was 5-CCAGTGAGAGGGGCTGAACC-3. The RQ of both genes expression was performed using comparative 2Ct method, where the amount of the target genes mRNA were normalized to an endogenous reference gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and relative to a control40.
Data were tested for normal distribution by ShapiroWilk test. Quantitative data were analyzed using Graph Prism 8 (GraphPad Software, Inc., CA, USA) to test the significance between different groups using analysis of variance (ANOVA) followed by Tukeys test. Data were presented as meanstandard error (SE). Significance was inferred at P<0.05.
Originally posted here:
Glycyrrhizic acid ameliorates submandibular gland oxidative stress, autophagy and vascular dysfunction in rat model of type 1 diabetes | Scientific...
- Breast Cancer Is Most Common Cancer In India, 1.38 Million Cases Diagnosed Annually. Know Estimated Incidence By 2030 - ABP Live - November 26th, 2023
- What Is Amyloidosis? All About The Rare Disease That Pervez Musharraf Suffered From - ABP Live - February 8th, 2023
- Autophagic death of neural stem cells mediates chronic stress-induced ... - November 7th, 2022
- Programmed cell death - Wikipedia - November 7th, 2022
- Hematopoietic Stem Cells | Hematopoiesis | Properties & Functions - September 4th, 2022
- Canadian Blood Services Stem Cells for Life - September 4th, 2022
- Devastation over death of schoolgirl, 11, who hoped she was beating cancer - Leicestershire Live - September 4th, 2022
- From optimized stem cell transplants to CAR T cell therapy: Advancing options for cancer, HIV and more - City of Hope - September 4th, 2022
- Scientists unlock the key to immortality in jellyfish - Syfy - September 4th, 2022
- Forge Biologics Reports Positive Clinical Data on Brain Development and Motor Function from the RESKUE Novel Phase 1/2 Gene Therapy Trial in Patients... - September 4th, 2022
- Menin Inhibitors Have Potential to Become the Next Class of Targeted Therapy in AML - Targeted Oncology - September 4th, 2022
- Wanted murder suspect John Belfield believed to still be in the UK as two more arrested over death of Thomas Campbell - The Manc - September 4th, 2022
- Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study | Blood Cancer Journal... - July 8th, 2022
- Can minds persist when they are cut off from the world? - Livescience.com - July 8th, 2022
- Black Adolescent Young Adults With AML Have Worse Outcomes Vs White Population - Cancer Network - July 8th, 2022
- Akari Therapeutics Announces First Patient to Complete Course of Treatment in the Phase III Part A Clinical Trial of Investigational Nomacopan in... - July 8th, 2022
- How abortion ruling could affect IVF and embryonic research - The Almanac Online - July 8th, 2022
- This Morning viewers 'in tears' after boy meets donor who saved his life - Devon Live - July 8th, 2022
- Alpena detective: 'Good people out there' | News, Sports, Jobs - Alpena News - July 8th, 2022
- 'I miss my best friend': Five-year-old runs 10k to honour girl who died from rare brain tumour - Teesside Live - July 8th, 2022
- Humanigen Announces Peer-Reviewed Publication in Thorax Supporting Early Treatment of Hospitalized COVID-19 Patients with Lenzilumab Guided by... - July 8th, 2022
- Novartis AG, AstraZeneca Plc, and Pfizer Inc Among Leading Companies in the Thyroid Cancer Pipeline Products Market | Globaldata Plc - Yahoo Finance - July 8th, 2022
- A New Strategy Could Turn the Tide in Stem Cell GVHD - Medical Device and Diagnostics Industry - January 17th, 2022
- Vertex type 1 diabetes vs stem cell therapy - The Boar - January 17th, 2022
- Two-Year OS Doubles for Patients With Philadelphia-Positive Relapsed ALL After HSCT - AJMC.com Managed Markets Network - January 17th, 2022
- Nowakowski Considers CD19 Therapy in Transplant-Ineligible DLBCL - Targeted Oncology - January 17th, 2022
- Psaki demolishes Doocy with stats as he tries to claim covid now an illness of the vaccinated - newsconcerns - January 17th, 2022
- Doctors and Researchers Probe How COVID-19 Attacks the Heart - The Scientist - January 17th, 2022
- Who does donated blood that's direly needed help? - WTOP - January 17th, 2022
- Places Where Omicron is Most Contagious Eat This Not That - Eat This, Not That - January 17th, 2022
- UHN and U of T receive $24-million federal grant for transplant research - News@UofT - January 17th, 2022
- Stem cells in cancer therapy: opportunities and challenges - January 1st, 2022
- Life After Brain Death: Is the Body Still 'Alive'? | Live ... - January 1st, 2022
- Autologous Adult Stem Cells in the Treatment of Stroke | SCCAA - Dove Medical Press - January 1st, 2022
- Stem Cell Mimicking Nanoencapsulation for Targeting Arthrit | IJN - Dove Medical Press - January 1st, 2022
- Cellular Therapies Fill Unmet Needs in R/R Multiple Myeloma - Targeted Oncology - January 1st, 2022
- Upregulated expression of actin-like 6A is a risk factor | CMAR - Dove Medical Press - January 1st, 2022
- COVID-19 Takes a Toll on People with Blood Cancers and Disorders - Cancer Health Treatment News - January 1st, 2022
- Mental health disorders and heart diseases - Rising Kashmir - January 1st, 2022
- Research breakthrough could mean better treatment for patients with most deadly form of brain tumor - EurekAlert - October 26th, 2021
- European Commission Approves Merck's KEYTRUDA (pembrolizumab) Plus Chemotherapy as Treatment for Certain Patients With Locally Recurrent Unresectable... - October 26th, 2021
- European Commission Selects Humanigen's Lenzilumab as One of the 10 Most Promising Treatments for COVID-19 - Galveston County Daily News - October 26th, 2021
- Everything You Need To Know About COVID Booster Shots - Colorado Times Recorder - October 26th, 2021
- Stem cells and their role in lung transplant rejection - Michigan Medicine - October 5th, 2021
- Losing Your Hair? You Might Blame the Great Stem Cell Escape. - The New York Times - October 5th, 2021
- Will humans ever be immortal? - Livescience.com - October 5th, 2021
- Healthcare Researchers Are Putting HUMAN Immune Systems In Pigs To Study Illnesses-Here's The Tech Behind It - Tech Times - October 5th, 2021
- Why Bezos, Musk, Page and other billionaires want to live forever - New York Post - October 5th, 2021
- Faster healing of wounds can decrease pain and suffering and save lives - ABC 12 News - October 5th, 2021
- U.S. FDA Approves Kite's Tecartus as the First and Only Car T for Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia - Business... - October 5th, 2021
- Skeletons' broken clavicles tell a centuries-old tale of humans and horses - Massive Science - October 5th, 2021
- Environmental Factor - August 2021: Extramural Papers of the Month - Environmental Factor Newsletter - August 4th, 2021
- Role of traumatic brain injury in the development of glioma | JIR - Dove Medical Press - August 4th, 2021
- Targeted Therapeutics Market: Increase in Incidence of Cancer to Drive Global Market - BioSpace - August 4th, 2021
- Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Ca | CMAR - Dove Medical Press - August 4th, 2021
- Novel CAR-T Cell Therapy Produces Early and Deep Responses in Certain Patients with Multiple Myeloma - Curetoday.com - June 7th, 2021
- Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver - Science Advances - June 7th, 2021
- Cancer research: New advances and innovations - Medical News Today - June 7th, 2021
- Fulvestrant Alone Found to be Superior to Venetoclax/Fulvestrant Combo in ER+/HER2- Breast Cancer - Targeted Oncology - June 7th, 2021
- Merck's KEYTRUDA Given After Surgery Reduced the Risk of Disease Recurrence or Death by 32% Versus Placebo as Adjuvant Therapy in Patients With Renal... - June 7th, 2021
- Stem cell study illuminates the cause of an inherited heart disorder | Penn Today - Penn Today - February 14th, 2021
- The race to treat a rare, fatal syndrome may help others with common disorders like diabetes - Science Magazine - February 14th, 2021
- Jasper Therapeutics Announces Positive Data from Phase 1 Clinical Trial of JSP191 as Targeted Stem Cell Conditioning Agent in Patients with... - February 14th, 2021
- The Very First Signs of an Immune Response Have Been Filmed in a Developing Embryo - ScienceAlert - February 14th, 2021
- Arlo's Army needs stem cell donor as mum begs for help to save three-year-old's life - Glasgow Live - February 14th, 2021
- Astellas and Seagen Announce Phase 3 Trial Results Demonstrating Survival Advantage of PADCEV (enfortumab vedotin-ejfv) in Patients with Previously... - February 14th, 2021
- [Full text] Successful Use of Nivolumab in a Patient with Head and Neck Cancer Aft | OTT - Dove Medical Press - February 14th, 2021
- The drug treatments offering the best hope of a way out of the Covid crisis - Telegraph.co.uk - February 14th, 2021
- In the war against Covid, an arsenal of drugs is on the way - Telegraph.co.uk - February 14th, 2021
- Kat Wests husband, Jeff West, sentenced to 16 years in wifes death - AL.com - February 9th, 2021
- Harnessing the Potential of Cell and Gene Therapy - OncLive - February 9th, 2021
- I Survived Cancer, and Then I Needed to Remember How to Live - The Atlantic - February 9th, 2021
- [Full text] Higher Red Blood Cell Distribution Width is a Poor Prognostic Factor f | CMAR - Dove Medical Press - February 9th, 2021
- West Belfast woman to be remembered in special TV documentary - Belfast Live - January 29th, 2021
- UTV documentary tells of young Belfast woman's lasting legacy to promote stem cell donation - The Irish News - January 29th, 2021
- L-MIND Trial Results Show CD19 Antibody Is Reasonable in R/R DLBCL - Targeted Oncology - January 29th, 2021
- Vertex Announces FDA Clearance of Investigational New Drug (IND) Application for VX-880, a Novel Cell Therapy for the Treatment of Type 1 Diabetes... - January 29th, 2021
- If I Have Cancer, Dementia or MS, Should I Get the Covid Vaccine? - Kaiser Health News - January 29th, 2021
- Experimental taphonomy of organelles and the fossil record of early eukaryote evolution - Science Advances - January 29th, 2021
- Propanc Biopharma Appoints Belen Toledo to Evaluate Impact of Proenzyme Therapy on Tumor Microenvironment - Business Wire - January 29th, 2021